MOLINARI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 3.763
EU - Europa 2.417
AS - Asia 1.829
SA - Sud America 334
AF - Africa 41
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.396
Nazione #
US - Stati Uniti d'America 3.703
IT - Italia 807
SG - Singapore 648
CN - Cina 565
GB - Regno Unito 448
SE - Svezia 314
BR - Brasile 276
DE - Germania 238
HK - Hong Kong 234
VN - Vietnam 131
RU - Federazione Russa 110
UA - Ucraina 94
FI - Finlandia 66
NL - Olanda 64
FR - Francia 59
IE - Irlanda 43
KR - Corea 42
IN - India 41
CA - Canada 39
ID - Indonesia 37
TR - Turchia 33
LT - Lituania 32
BE - Belgio 31
BG - Bulgaria 28
AR - Argentina 24
CZ - Repubblica Ceca 19
PL - Polonia 18
JP - Giappone 17
ZA - Sudafrica 17
BD - Bangladesh 16
MX - Messico 16
ES - Italia 13
MY - Malesia 11
PK - Pakistan 11
EC - Ecuador 10
TW - Taiwan 9
AU - Australia 8
NO - Norvegia 7
CH - Svizzera 6
CL - Cile 6
CO - Colombia 6
AT - Austria 5
IQ - Iraq 5
KE - Kenya 5
SA - Arabia Saudita 5
TN - Tunisia 5
IL - Israele 4
IR - Iran 4
JO - Giordania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
MA - Marocco 3
PY - Paraguay 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
PE - Perù 2
PT - Portogallo 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.396
Città #
Santa Clara 433
Ashburn 416
Singapore 395
Fairfield 316
Chandler 248
Southend 248
Hong Kong 232
Woodbridge 213
Hefei 179
Ann Arbor 148
Nyköping 139
Modena 133
Houston 131
Wilmington 131
Seattle 123
Jacksonville 106
London 100
Los Angeles 93
Dearborn 90
Cambridge 79
Beijing 73
New York 60
Chicago 50
Milan 47
Ho Chi Minh City 46
Shanghai 42
Helsinki 39
Rome 39
Seoul 39
Bologna 37
Moscow 36
The Dalles 35
Munich 33
San Diego 33
São Paulo 33
Dublin 32
Jakarta 32
Council Bluffs 28
Fremont 28
Princeton 28
Sofia 28
Brussels 23
Enschede 20
Buffalo 19
Hanoi 19
Eugene 18
Izmir 18
Phoenix 18
Salt Lake City 18
Dallas 17
Denver 17
Reggio Emilia 15
Brno 14
Florence 14
Stockholm 14
Toronto 14
Elk Grove Village 13
Chennai 12
Johannesburg 12
Montreal 12
Orem 12
Redwood City 12
Tokyo 12
Bremen 11
Brooklyn 11
Columbus 11
Frankfurt am Main 11
San Jose 11
Warsaw 11
Atlanta 10
Dong Ket 10
Poplar 10
Grafing 9
Southwark 9
Bari 8
Boston 8
Kent 8
Parma 8
Rio de Janeiro 8
Turin 8
Belo Horizonte 7
Des Moines 7
Guarulhos 7
Jinan 7
Kunming 7
New Delhi 7
Carpi 6
Changsha 6
Falls Church 6
Mexico City 6
Mumbai 6
Naples 6
Nuremberg 6
Paris 6
Turku 6
Amsterdam 5
Bloomsbury 5
Boardman 5
Dhaka 5
Formigine 5
Totale 5.397
Nome #
IL FATTORE DI TRASCRIZIONE MEF2C AI CROCEVIA TRA PROLIFERAZIONE, SVILUPPO E DIFFERENZIAMENTO MUSCOLARE 631
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 429
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 390
NF-YA splice variants have different roles on muscle differentiation 359
Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition 347
Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells 346
NF-Y splice variants differentially affect skeletal myogenesis 323
Alternative splicing of transcription factors genes in muscle physiology and pathology 309
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 301
PROLINE ISOMERASE PIN1 REPRESSES TERMINAL DIFFERENTIATION AND MYOCYTE ENHANCER FACTOR 2C FUNCTION IN SKELETAL MUSCLE CELLS 294
A novel complex regulates cardiac actin gene expression through interaction of Emb, a class VI POU domain protein, MEF2D, and the histone transacetylase p300 286
The in vivo form of the murine class VIPOU protein Emb is larger than that encoded by previously described transcripts 266
Proline Isomerase Pin1 represses terminal differentiation and Myocyte Enhancer Factor 2C function in Skeletal Muscle Cells 260
Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb. Ganassi M, Badodi S, Polacchini A, Baruffaldi F, Battini R, Hughes SM, Hinits Y, Molinari S. Biochim Biophys Acta. 2014 Jul;1839(7):559-70. doi: 10.1016/j.bbagrm.2014.05.003. Epub 2014 May 17. 257
A POTENTIAL ROLE OF MEF2C IN THE MYOGENIC PROGRESSION BESIDE TERMINAL DIFFERENTIATION 252
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 243
Regulation of Mef2c activity by alternative splicing in zebrafish muscle development 234
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 222
PIN1: a putative molecular target to protect skeletal muscle against age-related muscle loss 209
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 204
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 177
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 162
Induction of Calbindin-D28K by 1,25-dihydroxyvitamin D3 in cultured chicken intestinal cells 159
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 146
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression 140
Metabolome in Tibialis and Soleus Muscles in Wild-Type and Pin1 Knockout Mice through High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy 133
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 131
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 122
Differential response of embryonic and fetal myoblasts to TGF-beta. A possible regulatory mechanism of skeletal histogenesis 122
Absence of mef2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle 121
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 116
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 116
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 110
Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor 105
The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4 92
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 91
Phosphorylation-dependent binding of MEF2 to the A/T rich element in the muscle creatine kinase enhancer correlates with lack of expression in embryonic mammalian muscle 69
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 53
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 36
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 33
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 28
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 22
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 19
Totale 8.465
Categoria #
all - tutte 30.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021389 0 0 0 0 0 38 39 65 38 114 47 48
2021/2022674 61 50 48 46 21 47 38 36 82 47 137 61
2022/2023821 94 107 57 92 59 103 31 76 81 25 45 51
2023/2024735 31 47 74 54 113 70 103 51 14 22 76 80
2024/20251.986 73 35 110 139 322 299 198 128 210 93 171 208
2025/20262.110 267 142 260 488 648 305 0 0 0 0 0 0
Totale 8.465